{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:45:14Z","timestamp":1784191514046,"version":"3.55.0"},"reference-count":31,"publisher":"Baishideng Publishing Group Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2004]]},"DOI":"10.3748\/wjg.v10.i5.747","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T11:09:48Z","timestamp":1442574588000},"page":"747","source":"Crossref","is-referenced-by-count":25,"title":["Clinical evaluation of four one-week triple therapy regimens in eradicating<i>Helicobacter pylori<\/i>infection"],"prefix":"10.3748","volume":"10","author":[{"given":"Chuan-Yong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(02)00006-3"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sarg&yacute;n M, Uygur-Bayramicli O, Sarg&yacute;n H, Orbay E, Yavuzer D, Yayla A. Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J Gastroenterol 2003;9:1126-1128.","DOI":"10.3748\/wjg.v9.i5.1126"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200305000-00009"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions. World J Gastroenterol 2003;9:755-758.","DOI":"10.3748\/wjg.v9.i4.755"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012120-00007"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2002.02735.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Wolle K, Leodolter A, Malfertheiner P, K&ouml;nig W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002;51:705-709.","DOI":"10.1099\/0022-1317-51-8-705"},{"key":"ref8","unstructured":"Bruley des Varannes S. [How to treat after Helicobacter pylori eradication failure]. Gastroenterol Clin Biol 2003;27:478-483."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Hua JS, Bow H, Zheng PY, Khay-Guan Y. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore. World J Gastroenterol 2000;6:119-121.","DOI":"10.3748\/wjg.v6.i1.119"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1564-1567.2002"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.4.675"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, Yakovenko EP, Gulyaev PV, Fedchenko VI. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-882.","DOI":"10.3748\/wjg.v8.i5.879"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2508(03)00030-5"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01434.x"},{"key":"ref15","unstructured":"Houben MH, van de Beek D, Hensen EF, de Craen AJ, van 't Hoff BW, Tytgat GN. Helicobacter pylori eradication therapy in The Netherlands. Scand J Gastroenterol Suppl 1999;230:17-22."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00949.x"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.0160s1024.x"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01118.x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01130.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00471.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00580.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00535.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199908002-00003"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199908002-00005"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"M&eacute;graud F, Lehn N, Lind T, Bayerd&ouml;rffer E, O'Morain C, Spiller R, Unge P, van Zanten SV, Wrangstadh M, Burman CF. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999;43:2747-2752.","DOI":"10.1128\/AAC.43.11.2747"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00468-X"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01278.x"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2001.00249.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02553.x"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01299.x"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i5\/747.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T18:25:13Z","timestamp":1567189513000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v10\/i5\/747.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v10.i5.747","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2004]]}}}